Dr. Myles Minter

William Blair

Recent Articles

What Do Analysts Think About the Biopharma Set on Transforming Psychiatry 04/09/2026

Alto Neuroscience Inc. (ANRO:NYSE) is a clinical-stage biopharmaceutical company focused on transforming psychiatry through novel drug candidates.

Biotech to Fast Track Phase 3 Depression Trial 10/30/2025

Alto Neuroscience Inc. (ANRO:NYSE) intends to carry out this newly added study, supported by a recent financing, and the previously planned Phase 2b trial simultaneously, noted a William Blair report.